Traditional Chinese medicine composition for protecting liver and intestines of aquatic animals and preparation method thereof
Through the fermentation of water extracts of Salvia miltiorrhiza, Eucommia ulmoides, Apricotum, Astragalus, Yinchen, Dijincao and aqueous ethanol extraction, combined with the preparation method of auxiliary materials, a Chinese medicine composition for liver protection and intestine protection for aquatic animals was formed, and the solution was solved The single effects and side effects of existing drugs have achieved the effect of efficiently protecting the liver and intestines of aquatic animals.
Patent Information
- Application Number
- CN202410852271.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-27
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-06-27
AI Technical Summary
Most of the current drugs used for liver and intestinal diseases of aquatic animals are Western medicines, which have problems with single effects, side effects and drug resistance. The digestion and absorption rate of traditional Chinese medicine products is low, resulting in a long course of treatment and slow effect.
The water extract of Salvia miltiorrhiza, Eucommia ulmoides, Apricot 5, Astragalus, Artemisia chen, and Dijincao was fermented and extracted by aqueous ethanol solution, combined with the mixture of auxiliary materials taurine, vitamins and starch to form liver protection for aquatic animals. Intestinal Chinese medicine composition.
It significantly improves the activity of superoxide dismutase and catalase in the liver of aquatic animals, reduces the MDA content, and increases the activity of intestinal midgut amylase and intestinal lipase, which has the effect of efficiently protecting the liver and intestinal tract and has low side effects. No residue.
Smart Images

Figure BDA0004917690270000121
Abstract
Description
Technical Field
[0001] The invention relates to a Chinese medicinal composition for aquatic animals, and in particular to a Chinese medicinal composition for protecting liver and intestines of aquatic animals and a preparation method thereof. Background Art
[0002] With the advancement of agricultural technology, aquatic animal breeding, especially aquaculture, has achieved rapid development; however, with the emergence of high-density and intensive breeding models, the aquaculture water environment has deteriorated, and due to drug abuse and other reasons, hepatointestinal diseases in aquaculture fish have become increasingly prominent.
[0003] Fish hepatoenteropathy has become one of the serious diseases of major marine and freshwater aquaculture fish; although this type of disease is not contagious, its harm and consequences often far exceed those of infectious diseases, especially aggravating the degree of harm caused by infectious diseases.
[0004] There are many types of drugs currently used to treat liver and intestinal diseases in aquatic animals, most of which are Western medicines. However, these Western medicines have a single effect and are prone to side effects and drug resistance. In addition, most of the Chinese medicine products for liver and intestinal diseases in aquatic animals on the market are made by compounding Chinese medicine raw materials after crushing. The digestion and absorption rate of the drugs is low, and the effective ingredients cannot be fully utilized, resulting in a long clinical treatment course and slow effect.
[0005] Therefore, developing a Chinese medicinal composition for aquatic animals which is highly effective, has low side effects and leaves no residue in the fish body and can improve the liver and intestine protection of aquatic animals is one of the technical problems that urgently need to be solved. Summary of the invention
[0006] The present invention aims at the above technical problems and thus proposes a technical solution of a Chinese medicine composition for protecting liver and intestines of aquatic animals and a preparation method thereof.
[0007] The technical solution of the present invention is as follows:
[0008] On the one hand, the present invention provides a method for preparing a liver and intestine protecting Chinese medicine composition for aquatic animals, comprising the steps of using salvia miltiorrhiza, eucommia bark, acanthopanax senticosus, astragalus, capillaris, and euphorbia pulex to extract the extract, fermenting the extract, then extracting with ethanol aqueous solution, post-treating, and mixing with auxiliary materials.
[0009] The preparation method specifically comprises the following steps:
[0010] Step 1: Grind salvia miltiorrhiza, eucommia bark, Acanthopanax senticosus, astragalus, capillaris, and euphorbia pulex to obtain powders respectively; weigh the powders according to the following weight parts: 1-3 parts of salvia miltiorrhiza, 0.5-2.8 parts of eucommia bark, 0.4-2.2 parts of Acanthopanax senticosus, 1-2.5 parts of astragalus, 1.5-3.5 parts of capillaris, and 2-5 parts of euphorbia pulex; and then mix to obtain a powder mixture;
[0011] Step 2: Mix the powder mixture with water in a mass ratio of 1:20-40, heat and stir, and cool to obtain a coolant;
[0012] Step 3: Mix the cooling liquid with the fermentation bacteria to obtain a pre-fermentation solution, and perform anaerobically fermentation on a shaking bed at 30-38°C for 20-40 hours to obtain a fermentation liquid; wherein the fermentation bacteria is Lactobacillus plantarum 24809 and Lactobacillus delbrueckii subsp. bulgaricus 25077 is composed of live bacteria in a ratio of 3-6:1, and the total live bacteria concentration of the fermentation bacteria in the solution before fermentation is 2.4×10 7 -4.2×10 8 cfu / mL;
[0013] Step 4: sterilizing the fermentation broth and concentrating under reduced pressure to obtain a concentrate 1;
[0014] Step 5: the concentrate 1 is mixed with an ethanol aqueous solution, extracted to obtain an extract, and filtered to obtain a filtrate;
[0015] Step 6: The filtrate is concentrated under reduced pressure and freeze-dried to obtain a dry material;
[0016] Step 7: The dried material is mixed with taurine, vitamins and starch in a mass ratio of 1:(0.1-1):(0.1-1):(30-80) to obtain the Chinese medicine composition.
[0017] Furthermore, in step 1, the particle size of each powder is between 0.02 mm and 1 mm.
[0018] Furthermore, in step 1, the mass ratio of Artemisia capillaris to Herba Euphorbiae is 1:1.2-2.
[0019] Furthermore, in step 2, the temperature of heating and stirring is 55-70° C., the time is 5-20 hours, and the rotation speed can be 60-500 rpm.
[0020] Further, in step 2, cooling to 20-28°C.
[0021] Furthermore, in step 3, the shaking table anaerobic fermentation has a rotation frequency of 30-300 rpm and an amplitude of 15-30 mm.
[0022] Further, in step 3, the plant lactobacillus
[0023] 24809:Lact ipl ant i bac ill us parap l antarum 24809, China Industrial Microbiological Culture Collection Management Center.
[0024] Further, in step 3, Lactobacillus delbrueckii subsp. bulgaricus
[0025] 25077:Lactobac ill us de l brueck ii subsp.bu l gar i cus 25077, China Industrial Microbiological Culture Collection Management Center.
[0026] Furthermore, in step 4, the reduced pressure concentration temperature is 58-62°C.
[0027] Furthermore, in step 4, the concentrate is concentrated under reduced pressure until the mass of the concentrate 1 is 0.3-1.2 times the mass of the powder mixture.
[0028] Furthermore, in step 5, the concentration of the ethanol aqueous solution is 30-55wt%.
[0029] Furthermore, in step 5, the mass ratio of the concentrate 1 to the ethanol aqueous solution is 1:20-100.
[0030] Furthermore, in step 5, the leaching temperature is 40-55° C., and the time is 5-20 hours. The leaching is performed by stirring.
[0031] Furthermore, in step 6, the temperature of the reduced pressure concentration is 53-57°C.
[0032] Furthermore, in step 6, the freeze-drying temperature is -50°C to -25°C.
[0033] Furthermore, in step 6, freeze drying is performed until the water content mass ratio is less than 6.7%.
[0034] Furthermore, the preparation method specifically comprises the following steps:
[0035] Step 1: Grind salvia miltiorrhiza, eucommia bark, Acanthopanax senticosus, astragalus, capillaris, and Herba Euphorbiae to obtain powders respectively; weigh the powders according to the following weight proportions: 1-3 parts of salvia miltiorrhiza, 0.5-2.8 parts of eucommia bark, 0.4-2.2 parts of Acanthopanax senticosus, 1-2.5 parts of astragalus, 1.5-3.5 parts of capillaris, and 2-5 parts of Herba Euphorbiae; the weight ratio of capillaris to Herba Euphorbiae is 1:1.2-2; and then mix to obtain a powder mixture;
[0036] Step 2: Mix the powder mixture with water in a mass ratio of 1:20-40, heat to 55-70° C., stir for 5-20 hours, and cool to obtain a coolant;
[0037] Step 3: Mix the cooling liquid with the fermentation bacteria to obtain a pre-fermentation solution, and perform anaerobically fermentation on a shaking bed at 30-38°C for 20-40 hours to obtain a fermentation liquid; wherein the fermentation bacteria is Lactobacillus plantarum 24809 and Lactobacillus delbrueckii subsp. bulgaricus 25077 is composed of live bacteria in a ratio of 3-6:1, and the total live bacteria concentration of the fermentation bacteria in the solution before fermentation is 2.4×10 7 -4.2×10 8 cfu / mL;
[0038] Step 4: sterilize the fermentation broth and concentrate under reduced pressure to 0.3-1.2 times the mass of the powder mixture to obtain a concentrate 1;
[0039] Step 5: the concentrate 1 is mixed with a 30-55 wt % ethanol aqueous solution in a mass ratio of 1:20-100, stirred and extracted at 40-55° C. for 5-20 hours to obtain an extract, and filtered to obtain a filtrate;
[0040] Step 6: The filtrate is concentrated under reduced pressure and freeze-dried to obtain a dry material;
[0041] Step 7: The dried material is mixed with taurine, vitamins and starch in a mass ratio of 1:(0.1-1):(0.1-1):(30-80) to obtain the Chinese medicine composition.
[0042] On the other hand, the present invention also provides a liver and intestine protecting Chinese medicinal composition for aquatic animals prepared according to the preparation method.
[0043] Beneficial effects:
[0044] The invention uses water extraction of salvia miltiorrhiza, eucommia bark, acanthopanax senticosus, astragalus, capillaris and euphorbia pulex, and the extract materials are fermented, then extracted with ethanol aqueous solution, post-treated, mixed with auxiliary materials and the like, and the prepared composition can significantly improve the activities of superoxide dismutase SOD and catalase CAT in the liver and reduce the MDA content, and can also greatly improve the activities of intestinal amylase and intestinal lipase in the intestine; the prepared composition has a highly effective protective effect on the liver and intestine of aquatic animals; and uses plant Chinese patent medicine raw materials, has low side effects and has no residue in the fish body.
[0045] The composition prepared by the present invention is fed for 100 days at an addition amount of 0.2wt%, so that the superoxide dismutase SOD activity in the liver of seabass is increased to 10.75±0.97U / mg prot, the catalase CAT activity is increased to 3.85±0.41U / mg prot, and the malondialdehyde MDA content is reduced to 1.64±0.21nmol / mg prot; the intestinal amylase activity in the intestine is increased to 504.7U / g prot, and the intestinal lipase activity is increased to 24.18U / gprot.
[0046] The Artemisia capillaris and Euphorbia euphorbiae can increase the effect of the composition in protecting the liver and maintaining the intestines. The active ingredients provided by the two have a mutually reinforcing relationship in increasing liver and intestinal indices. Especially when the dosage ratio of the two reaches the range of 1:1.2-2, the obtained composition has a better effect in maintaining liver and intestinal health.
[0047] The present invention adopts plant lactobacillus 24809 and Lactobacillus delbrueckii subsp. bulgaricus 25077, fermented to prepare the composition of the present invention, the protective effect of the liver and intestines is better. The two can be fermented together to produce a complementary relationship, making the composition more effective, and having a mutually promoting relationship in increasing the liver and intestines protective effect.
[0048] The fermentation bacteria used in the present invention can significantly promote the liver and intestine protection effect of the composition, and has a better promoting effect on promoting enzyme activity in the liver and intestines and reducing the content of malondialdehyde (MDA) than other bacteria. 24809 and Lactobacillus delbrueckii subsp. bulgaricus 25077 will produce better results if the ratio of live bacteria is 3-6:1. DETAILED DESCRIPTION
[0049] The present invention will be described below in conjunction with specific embodiments, and various effects of the present invention will be more clearly presented. It should be understood by those skilled in the art that these specific embodiments are used to illustrate the present invention, rather than to limit the present invention.
[0050] Unless otherwise specified, various raw materials, reagents, instruments and equipment used in the present invention can be purchased from the market or prepared by existing methods.
[0051] 1. Preparation of the composition
[0052] Composition 1:
[0053] The preparation method of the composition is as follows:
[0054] Step 1: Grind salvia miltiorrhiza, eucommia ulmoides, acanthopanax senticosus, astragalus, capillaris, and herba euphorbiae respectively, and select powders with a particle size between 0.02 mm and 1 mm; weigh the powders according to the following mass parts: 2.2 parts of salvia miltiorrhiza, 1.8 parts of eucommia ulmoides, 1.5 parts of acanthopanax senticosus, 2.0 parts of astragalus, 2.4 parts of capillaris, and 3.6 parts of herba euphorbiae; the mass ratio of capillaris to herba euphorbiae is 1:1.5; and then mix to obtain a powder mixture;
[0055] Step 2: Mix the powder mixture with water in a mass ratio of 1:30, heat to 62°C, stir at 80 rpm for 10 hours, and cool to 25°C to obtain a coolant;
[0056] Step 3: The cooling liquid is mixed with the fermentation bacteria to obtain a pre-fermentation solution, and the fermentation bed is anaerobically fermented at 35° C. on a shaking bed for 32 hours with a shaking frequency of 70 rpm and an amplitude of 25 mm to obtain a fermentation liquid;
[0057] Among them, the fermentation bacteria is Lactobacillus plantarum 24809 and Lactobacillus delbrueckii subsp. bulgaricus 25077 is composed of live bacteria in a ratio of 5:1, and the total live bacteria concentration of the fermentation bacteria in the solution before fermentation is 1.8×10 8 cfu / mL;
[0058] Step 4: sterilize the fermentation broth, and concentrate under reduced pressure at 60°C to 0.5 times the mass of the powder mixture to obtain concentrate 1;
[0059] Step 5: the concentrate 1 was mixed with a 45 wt % ethanol aqueous solution in a mass ratio of 1:40, and the mixture was stirred and extracted at 50° C. and 75 rpm for 8 hours to obtain an extract, which was filtered to obtain a filtrate;
[0060] Step 6: The filtrate was concentrated under reduced pressure at 56°C, and freeze-dried at -30°C until the water content was about 5.43% to obtain a dry material;
[0061] Step 7: mixing the dried material with taurine, vitamins and starch in a mass ratio of 1:0.3:0.4:50 to obtain the Chinese medicine composition;
[0062] Among them, the vitamins are a mixture of vitamin B6 and vitamin C in a mass ratio of 1:3, and the starch is wheat starch.
[0063] Composition 2:
[0064] The preparation method of the composition is as follows:
[0065] Step 1: Grind salvia miltiorrhiza, eucommia ulmoides, acanthopanax senticosus, astragalus, capillaris, and herba euphorbiae respectively, and select powders with a particle size between 0.02 mm and 1 mm; weigh the powders according to the following weight parts: 2 parts salvia miltiorrhiza, 1.5 parts eucommia ulmoides, 2.0 parts acanthopanax senticosus, 1.8 parts astragalus, 2 parts capillaris, and 4 parts herba euphorbiae; the weight ratio of capillaris to herba euphorbiae is 1:2; and then mix to obtain a powder mixture;
[0066] Step 2: The powder mixture was mixed with water in a mass ratio of 1:32, heated to 63°C, stirred at 80 rpm for 8 hours, and cooled to 25°C to obtain a coolant;
[0067] Step 3: The cooling liquid is mixed with the fermentation bacteria to obtain a pre-fermentation solution, and the fermentation bed is anaerobically fermented at 34° C. on a shaking table for 38 hours with a rotation frequency of 70 rpm and an amplitude of 25 mm to obtain a fermentation liquid;
[0068] Among them, the fermentation bacteria is plant lactobacillus 24809 and Lactobacillus delbrueckii subsp. bulgaricus 25077 was composed of live bacteria in a ratio of 4:1, and the total live bacteria concentration of the fermentation bacteria in the solution before fermentation was 1.78×10 8 cfu / mL;
[0069] Step 4: sterilize the fermentation broth, and concentrate under reduced pressure at 62°C to 0.55 times the mass of the powder mixture to obtain concentrate 1;
[0070] Step 5: the concentrate 1 was mixed with a 40 wt % ethanol aqueous solution in a mass ratio of 1:45, and the mixture was stirred and extracted at 52° C. and 70 rpm for 10 hours to obtain an extract, which was filtered to obtain a filtrate;
[0071] Step 6: The filtrate was concentrated under reduced pressure at 55°C, and freeze-dried at -30°C until the water content was about 5.37% to obtain a dry material;
[0072] Step 7: mixing the dried material with taurine, vitamins and starch in a mass ratio of 1:0.3:0.4:50 to obtain the Chinese medicine composition;
[0073] Among them, the vitamins are a mixture of vitamin B6 and vitamin C in a mass ratio of 1:3, and the starch is wheat starch.
[0074] Composition 3: The difference from composition 1 is that 4 parts of Artemisia capillaris and 2 parts of Euphorbia pulegosa are used, and the ratio of the two is 1:0.2, and the other parts are the same.
[0075] Composition 4: The difference from composition 1 is that 1.5 parts of Artemisia capillaris and 4.5 parts of Euphorbia pulegosa are used in a ratio of 1:3, and the other parts are the same.
[0076] Composition 5: The difference from composition 1 is that the fermentation bacteria is plant lactobacillus 24809, the total concentration of live bacteria in the fermentation solution before fermentation is
[0077] 1.8×10 8 cfu / mL, and the others were the same.
[0078] Composition 6: The difference from composition 1 is that the fermentation bacteria is Lactobacillus delbrueckii subspecies bulgaricus 25077, the total concentration of live bacteria in the fermentation solution before fermentation was 1.8×10 8 cfu / mL, and the others were the same.
[0079] Composition 7: The difference from composition 1 is that the fermentation bacteria is Lactobacillus plantarum 24809 and Lactobacillus delbrueckii subsp. bulgaricus 25077 is composed of 1:1 live bacteria, and the total live bacteria concentration of the fermentation bacteria in the solution before fermentation is
[0080] 1.8×10 8 cfu / mL, and the others were the same.
[0081] Composition 8: The difference from composition 1 is that the fermentation bacteria is Lactobacillus plantarum 24809 and Lactobacillus delbrueckii subsp. bulgaricus 25077 is composed of 9:1 live bacteria, and the total live bacteria concentration of the fermentation bacteria in the solution before fermentation is
[0082] 1.8×10 8 cfu / mL, and the others were the same.
[0083] Composition 9: The fermentation bacteria is Lactobacillus casei
[0084] 23184(Lact icasei baci ll us paracasei 23184, China Industrial Microbiological Culture Collection Management Center), the total concentration of live bacteria in the fermentation solution before fermentation was 1.8×10 8 cfu / mL, and the others were the same.
[0085] Composition 10: The fermented bacteria is Lactobacillus plantarum 24809 and Lactobacillus casei 23184(Lact i case i bac ill us paracase i
[0086] 23184, China Industrial Microbiological Culture Collection Management Center) according to the ratio of live bacteria to 5:1, and the total live bacteria concentration of the fermentation bacteria in the solution before fermentation was 1.8×10 8 cfu / mL.
[0087] 2. Effect Test
[0088] The above compositions 1-10 were subjected to the following effect tests.
[0089] Select a number of perch ponds, put seedlings of the same period into the perch ponds at the same density, and then group and raise them. The grouping and raising methods are as follows:
[0090] Blank group: basic feed.
[0091] Composition 1 group: 0.2 wt% of composition 1 was added to the basic feed.
[0092] Composition 2 group: 0.2 wt% of composition 2 was added to the basic feed.
[0093] Composition 3 group: 0.2 wt% of composition 3 was added to the basic feed.
[0094] Group 4 of composition: 0.2 wt% of composition 4 was added to the basic feed.
[0095] Group Composition 5: 0.2 wt% of Composition 5 was added to the basic feed.
[0096] Group 6 of composition: 0.2 wt% of composition 6 was added to the basic feed.
[0097] Group Composition 7: 0.2 wt% of Composition 7 was added to the basic feed.
[0098] Group Composition 8: 0.2 wt% of Composition 8 was added to the basic feed.
[0099] Group Composition 9: 0.2 wt% of Composition 9 was added to the basic feed.
[0100] Group 10 of composition: 0.2 wt% of composition 10 was added to the basic feed.
[0101] Among them, the basic feed is Yongfeng 286# sea bass floating feed; Meishan Yongfeng Feed Co., Ltd.; implementation standard: Q / 73588211-2.1; specification: 25kg.
[0102] The perch in each group of ponds were fed three times a day. The feeding methods in the perch ponds corresponding to each group were as follows: the blank group was fed with basic feed; the composition 1-10 groups were fed with feed added with the corresponding composition for one day out of every three days, and the basic feed was used for the remaining days.
[0103] After 100 days of feeding, 10 seabass were randomly captured in each fish pond for sampling, and fish blood was collected to test the activities of superoxide dismutase SOD and catalase CAT in the liver and the content of malondialdehyde MDA in the liver, as well as the activities of intestinal amylase and intestinal lipase in the intestine.
[0104] The test indicators of sea bass liver and the comparison results of the effect compared with the blank group are shown in Table 1-2. The test indicators of sea bass intestine and the comparison results of the effect compared with the blank group are shown in Table 3-4.
[0105] Table 1 Test indicators of seabass liver
[0106] test SOD (U / mg prot) CAT (U / mg prot) MDA (nmol / mg prot) Blank Group 9.53±1.12 2.93±0.33 2.02±0.36 Composition 1 set 10.75±0.97 3.85±0.41 1.64±0.21 Composition 2 sets 10.69±1.21 3.81±0.37 1.66±0.38 Composition 3 groups 10.48±1.32 3.69±0.39 1.71±0.24 Composition 4 groups 10.61±1.17 3.77±0.30 1.68±0.19 Composition 5 groups 10.25±1.05 3.54±0.42 1.77±0.20 Composition 6 groups 10.13±0.91 3.48±0.35 1.80±0.31 Composition 7 groups 10.42±1.29 3.65±0.40 1.73±0.28 Composition 8 groups 10.57±1.35 3.73±0.31 1.69±0.15 Composition 9 groups 9.87±1.01 3.32±0.38 1.87±0.13 Composition 10 groups 10.09±1.24 3.45±0.44 1.81±0.24
[0107] Table 2 Comparison of the effects of liver test indicators in each group compared with the blank group
[0108] test SOD activity enhancement ratio CAT vitality improvement ratio MDA content reduction ratio Blank Group Composition 1 set 12.80% 31.40% 18.81% Composition 2 sets 12.17% 30.03% 17.82% Composition 3 groups 9.97% 25.94% 15.35% Composition 4 groups 11.33% 28.67% 16.83% Composition 5 groups 7.56% 20.82% 12.38% Composition 6 groups 6.30% 18.77% 10.89% Composition 7 groups 9.34% 24.57% 14.36% Composition 8 groups 10.91% 27.30% 16.34% Composition 9 groups 3.57% 13.31% 7.43% Composition 10 groups 5.88% 17.75% 10.40%
[0109] Table 3 Intestinal test indexes of sea bass
[0110]
[0111] Table 4 Comparison of the effects of intestinal test indicators in each group compared with the blank group
[0112] test Intestinal amylase activity improvement rate Intestinal lipase activity improvement rate Blank Group Composition 1 set 9.88% 22.17% Composition 2 sets 9.49% 21.26% Composition 3 groups 8.10% 18.03% Composition 4 groups 8.95% 20.06% Composition 5 groups 6.60% 14.60% Composition 6 groups 5.79% 12.82% Composition 7 groups 7.71% 17.16% Composition 8 groups 8.69% 19.40% Composition 9 groups 4.09% 8.85% Composition 10 groups 5.55% 12.16%
[0113] The activity of superoxide dismutase SOD, catalase CAT and malondialdehyde MDA content in the liver can reflect the health of the liver; the activity of intestinal amylase and intestinal lipase in the intestine is closely related to intestinal vitality.
[0114] The invention uses water extraction of salvia miltiorrhiza, eucommia bark, acanthopanax senticosus, astragalus, capillaris and euphorbia pulex, and the extract materials are fermented, then extracted with ethanol aqueous solution, post-treated, mixed with auxiliary materials and the like, and the prepared composition can significantly improve the activities of superoxide dismutase SOD and catalase CAT in the liver and reduce the MDA content, and can also greatly improve the activities of intestinal amylase and intestinal lipase in the intestine; the prepared composition has a protective effect on the liver and intestine of aquatic animals.
[0115] The composition prepared by the present invention is fed for 100 days at an addition amount of 0.2wt%, so that the superoxide dismutase SOD activity in the liver of seabass is increased to 10.75±0.97U / mgprot, the catalase CAT activity is increased to 3.85±0.41U / mgprot, and the malondialdehyde MDA content is reduced to 1.64±0.21nmol / mgprot; the intestinal amylase activity in the intestine is increased to 504.7U / gprot, and the intestinal lipase activity is increased to 24.18U / gprot.
[0116] From the test results of Group 1 and Group 3-4 of the composition of the present invention, it can be seen that the Artemisia capillaris and Herba Euphorbiae ivy of the present invention can increase the effect of the composition in protecting the liver and maintaining the intestines, and the active ingredients provided by the two have a mutually reinforcing relationship in increasing liver and intestinal indicators, especially when the dosage ratio of the two reaches the range of 1:1.2-2, the obtained composition has a better effect in maintaining liver and intestinal health.
[0117] The present invention adopts plant lactobacillus 24809 and Lactobacillus delbrueckii subsp. bulgaricus 25077, and fermented to prepare the composition of the present invention, the protective effect of the liver and intestines is better. The two are fermented together to produce a complementary relationship, making the composition more effective, and having a mutually promoting relationship in increasing the liver and intestines protective effect. The above conclusion can be obtained by comparing compositions 1, 7-8.
[0118] The fermentation bacteria used in the present invention can significantly promote the liver and intestine protection effect of the composition, and has a better promoting effect on promoting enzyme activity in the liver and intestines and reducing the content of malondialdehyde (MDA) than other bacteria. 24809 and Lactobacillus delbrueckii subsp. bulgaricus 25077 will produce better results if the ratio of live bacteria is 3-6:1.
[0119] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
Claims
1. A method for preparing a liver and intestine protecting Chinese medicinal composition for aquatic animals, characterized in that: The steps include: Step 1: Grind salvia miltiorrhiza, eucommia bark, Acanthopanax senticosus, astragalus, capillaris, and euphorbia pulex to obtain powders respectively; weigh the powders according to the following weight parts: 1-3 parts of salvia miltiorrhiza, 0.5-2.8 parts of eucommia bark, 0.4-2.2 parts of Acanthopanax senticosus, 1-2.5 parts of astragalus, 1.5-3.5 parts of capillaris, and 2-5 parts of euphorbia pulex; and then mix to obtain a powder mixture; Step 2: Mix the powder mixture with water in a mass ratio of 1:20-40, heat and stir, and cool to obtain a coolant; Step 3: The cooling liquid is mixed with the fermentation bacteria to obtain a pre-fermentation solution, and the fermentation bed is shaken at 30-38°C for 20-40 hours to obtain a fermentation liquid; wherein the fermentation bacteria are Lactobacillus plantarum CICC®24809 and Lactobacillus delbrueckii subspecies bulgaricus CICC®25077, and the live bacteria ratio is 3-6:1, and the total live bacteria concentration of the fermentation bacteria in the pre-fermentation solution is 2.4×10 7 -4.2×10 8 cfu / mL; Step 4: sterilizing the fermentation broth and concentrating under reduced pressure to obtain a concentrate 1; Step 5: the concentrate 1 is mixed with an ethanol aqueous solution, extracted to obtain an extract, and filtered to obtain a filtrate; Step 6: The filtrate is concentrated under reduced pressure and freeze-dried to obtain a dry material; Step 7: The dried material is mixed with taurine, vitamins and starch in a mass ratio of 1:(0.1-1):(0.1-1):(30-80) to obtain the traditional Chinese medicine composition; The heating and stirring temperature is 55-70°C and the time is 5-20 hours; The concentration of ethanol aqueous solution is 30-55wt%; The extraction temperature is 40-55°C and the time is 5-20 hours; The mass ratio of the concentrate 1 to the ethanol aqueous solution is 1:20-100; In step 4, the mixture is concentrated under reduced pressure until the mass of the concentrate 1 is 0.3-1.2 times the mass of the powder mixture; The aquatic animal is a fish.
2. The preparation method according to claim 1, characterized in that The mass ratio of Artemisia capillaris and Herba Euphorbiae is 1:1.2-2.
3. The preparation method according to claim 1, characterized in that: The shaking table for anaerobic fermentation has a rotation frequency of 100 rpm and an amplitude of 15-30 mm.
4. The preparation method according to claim 1, characterized in that: Freeze-dried to a water content of ≤ 6.7%.
5. A Chinese medicinal composition for protecting liver and intestine for aquatic animals prepared according to the preparation method according to any one of claims 1 to 4, characterized in that: The aquatic animal is a fish.
